Drugs / VAX161C
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01658800 | Sep 2012 → Sep 2013 | influenza | VaxInnate Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VAX161C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01658800 ↗ |
| Modality | Vaccine | “VAX161C is a vaccine” NCT01658800 ↗ |